PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 1, 2026Nature Communications0 citationsOpen Access

Pathogenic variants in the cohesin loader subunit MAU2 underlie a distinct Cornelia de Lange Syndrome subtype

IPIlaria ParentiAHAlina HestersMGMarta Gil-Salvador

Key Points

  • This research aims to clarify the role of MAU2 variants in Cornelia de Lange Syndrome (CdLS) and their functional consequences.
  • Analyzed 18 individuals with heterozygous MAU2 variants
  • Conducted functional analyses to assess the pathogenicity of variants
  • Utilized a heterozygous Mau2 knockout mouse model to observe phenotypic traits
  • Identified 15 distinct heterozygous MAU2 variants
  • In-frame variants impair NIPBL–MAU2 interaction while truncating variants cause MAU2 haploinsufficiency
  • Affected individuals display variable phenotypes including classic CdLS features and milder traits like short stature and microcephaly

Abstract

Abstract The role of the cohesin complex depends on the cohesin loader proteins NIPBL and MAU2. While NIPBL variants are a major cause of Cornelia de Lange Syndrome (CdLS), the role of MAU2 in disease is unclear. We describe 18 individuals carrying 15 heterozygous MAU2 variants and demonstrate pathogenicity through functional analyses. In-frame MAU2 variants predominantly impair NIPBL–MAU2 interaction, whereas truncating variants cause MAU2 haploinsufficiency and lead to NIPBL reduction. Most individuals exhibit a DNA methylation profile compatible with the CdLS episignature. We also describe two MAU2 -specific episignatures that reflect variant-dependent molecular consequences. Affected individuals display a wide range of phenotypes, from classic CdLS to milder presentations, with short stature and microcephaly as major features. A heterozygous Mau2 knockout mouse model recapitulates these traits, confirming the causal role of MAU2 disruption in vivo. Our study establishes MAU2 as a CdLS-associated gene and delineates a MAU2 -related chromatinopathy with variable expressivity.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Parenti et al. (2026) studied this question.

synapsesocial.com/papers/69ccb68116edfba7beb881c5https://doi.org/10.1038/s41467-026-71177-6
Ask AI
Helpful
Bookmark
Share
View Full Paper